← All companies

KARD

Kardigan, Inc.

KARD Nasdaq Pharmaceutical Preparations EDGAR ↗

$19.97

-0.85 -4.08%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$16.25 – $27.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws Jun 23, 2026

Other filings

4 Jul 13, 2026 SCHEDULE 13G Jun 29, 2026 SCHEDULE 13D Jun 29, 2026 SCHEDULE 13D Jun 25, 2026 4 Jun 24, 2026 3/A Jun 24, 2026 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jun 24, 2026 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Jun 24, 2026 4 Jun 22, 2026 4 Jun 22, 2026 4 Jun 22, 2026 4 Jun 22, 2026 4 Jun 22, 2026 4 Jun 22, 2026 4 Jun 22, 2026 4 Jun 22, 2026 4 Jun 22, 2026 4 Jun 22, 2026 4 Jun 22, 2026 4 Jun 22, 2026 424B4 FINAL PROSPECTUS 424(B)(4) Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 3 Jun 18, 2026 EFFECT Jun 17, 2026 S-1MEF Jun 17, 2026 3 Jun 17, 2026 S-8 Jun 17, 2026 CERT Jun 17, 2026 8-A12B Jun 15, 2026